Need help finding what you are looking for?
Contact Us
PUBLISHER: Transparency Market Research | PRODUCT CODE: 1487633
PUBLISHER: Transparency Market Research | PRODUCT CODE: 1487633
Europe Molecular Diagnostics Market (Product: Real-time PCR Systems, Liquid Handling Systems, and DNA Extraction Systems) - Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast, 2024-2034
PUBLISHED:
PAGES: 93 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Europe Molecular Diagnostics Market - Scope of Report
TMR's report on the Europe molecular diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the Europe molecular diagnostics market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the Europe molecular diagnostics market from 2024 to 2034.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the molecular diagnostics market.
| Market Snapshot | |
|---|---|
| Market Value in 2023 | US$ 5.9 Bn |
| Market Value in 2034 | US$ 17.3 Bn |
| CAGR | 10.2% |
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the Europe molecular diagnostics market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the Europe molecular diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the Europe molecular diagnostics market.
The report delves into the competitive landscape of the Europe molecular diagnostics market. Key players operating in the Europe molecular diagnostics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the Europe molecular diagnostics market profiled in this report.
Key Questions Answered in Europe molecular diagnostics Market Report:
- What is the sales/revenue generated by molecular diagnostics across all regions during the forecast period?
- What are the opportunities in the Europe molecular diagnostics market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which segment is expected to generate the highest revenue Europely in 2034?
- Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the Europe market?
Europe Molecular Diagnostics Market - Research Objectives and Research Approach
The comprehensive report on the Europe molecular diagnostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the Europe molecular diagnostics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the Europe molecular diagnostics market.
Product Code: TMRGL9434
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Europe Molecular Diagnostics Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Product Definition
- 4.1.2. Industry Evolution/Developments
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Europe Molecular Diagnostics Market Analysis and Forecast, 2020-2034
5. Key Insights
- 5.1. Pipeline Analysis
- 5.2. Key Product/Brand Analysis
- 5.3. Key Mergers & Acquisitions
- 5.4. COVID-19 Pandemic Impact on Industry
6. Europe Molecular Diagnostics Market Analysis and Forecast, by Product
- 6.1. Introduction & Definition
- 6.2. Key Findings/Developments
- 6.3. Market Value Forecast, by Product, 2020-2034
- 6.3.1. Real-time PCR Systems
- 6.3.1.1. LightCycler 480
- 6.3.1.2. PCRmax Eco 48
- 6.3.1.3. Applied Biosystems 7900HT
- 6.3.1.4. QuantStudio Real-Time PCR
- 6.3.1.5. ViiA 7 Real-Time PCR
- 6.3.1.6. C1000 Touch
- 6.3.1.7. ABI StepOnePlus Real-Time PCR
- 6.3.1.8. 5ABI 7500
- 6.3.1.9. AriaMx Real-time PCR System
- 6.3.1.10. CFX Connect
- 6.3.1.11. CFX384 Touch
- 6.3.1.12. MiniOpticon
- 6.3.1.13. Others
- 6.3.2. Liquid Handling Systems
- 6.3.2.1. epMotion
- 6.3.2.2. Biomek
- 6.3.2.3. Freedom EVO
- 6.3.2.4. Tecan D300e Digital Dispenser
- 6.3.2.5. Precision
- 6.3.2.6. JANUS
- 6.3.2.7. Others
- 6.3.3. DNA Extraction Systems
- 6.3.3.1. AutoMate Express
- 6.3.3.2. QIAcube
- 6.3.3.3. InnuPure
- 6.3.3.4. VERSA
- 6.3.3.5. Chemagic
- 6.3.3.6. Others
- 6.3.1. Real-time PCR Systems
- 6.4. Market Attractiveness Analysis, by Product
7. Europe Molecular Diagnostics Market Analysis and Forecast, by End-user
- 7.1. Introduction & Definition
- 7.2. Key Findings/Developments
- 7.3. Market Value Forecast, by End-user, 2020-2034
- 7.3.1. Hospitals
- 7.3.2. Diagnostics Laboratories
- 7.3.3. Academic & Research Institutes
- 7.3.4. Pharmaceutical & Biotechnology Companies
- 7.4. Market Attractiveness Analysis, by End-user
8. Europe Molecular Diagnostics Market Analysis and Forecast, by Country
- 8.1. Key Findings
- 8.2. Market Value Forecast, by Country, 2020-2034
- 8.2.1. Italy
- 8.2.2. Europe
- 8.2.3. U.K.
- 8.2.4. France
- 8.2.5. Germany
- 8.3. Market Attractiveness Analysis, by Country
9. Italy Molecular Diagnostics Market Analysis and Forecast
- 9.1. Introduction
- 9.2. Key Findings
- 9.3. Market Value Forecast, by Product, 2020-2034
- 9.3.1. Real-time PCR Systems
- 9.3.1.1. LightCycler 480
- 9.3.1.2. PCRmax Eco 48
- 9.3.1.3. Applied Biosystems 7900HT
- 9.3.1.4. QuantStudio Real-Time PCR
- 9.3.1.5. ViiA 7 Real-Time PCR
- 9.3.1.6. C1000 Touch
- 9.3.1.7. ABI StepOnePlus Real-Time PCR
- 9.3.1.8. 5ABI 7500
- 9.3.1.9. AriaMx Real-time PCR System
- 9.3.1.10. CFX Connect
- 9.3.1.11. CFX384 Touch
- 9.3.1.12. MiniOpticon
- 9.3.1.13. Others
- 9.3.2. Liquid Handling Systems
- 9.3.2.1. epMotion
- 9.3.2.2. Biomek
- 9.3.2.3. Freedom EVO
- 9.3.2.4. Tecan D300e Digital Dispenser
- 9.3.2.5. Precision
- 9.3.2.6. JANUS
- 9.3.2.7. Others
- 9.3.3. DNA Extraction Systems
- 9.3.3.1. AutoMate Express
- 9.3.3.2. QIAcube
- 9.3.3.3. InnuPure
- 9.3.3.4. VERSA
- 9.3.3.5. Chemagic
- 9.3.3.6. Others
- 9.3.1. Real-time PCR Systems
- 9.4. Market Value Forecast, by End-user, 2020-2034
- 9.4.1. Hospitals
- 9.4.2. Diagnostics Laboratories
- 9.4.3. Academic & Research Institutes
- 9.4.4. Pharmaceutical & Biotechnology Companies
- 9.5. Market Value Forecast, by Country, 2020-2034
- 9.5.1. U.S.
- 9.5.2. Canada
- 9.6. Market Attractiveness Analysis
- 9.6.1. By Product
- 9.6.2. By End-user
10. Spain Molecular Diagnostics Market Analysis and Forecast
- 10.1. Introduction
- 10.2. Key Findings
- 10.3. Market Value Forecast, by Product, 2020-2034
- 10.3.1. Real-time PCR Systems
- 10.3.1.1. LightCycler 480
- 10.3.1.2. PCRmax Eco 48
- 10.3.1.3. Applied Biosystems 7900HT
- 10.3.1.4. QuantStudio Real-Time PCR
- 10.3.1.5. ViiA 7 Real-Time PCR
- 10.3.1.6. C1000 Touch
- 10.3.1.7. ABI StepOnePlus Real-Time PCR
- 10.3.1.8. 5ABI 7500
- 10.3.1.9. AriaMx Real-time PCR System
- 10.3.1.10. CFX Connect
- 10.3.1.11. CFX384 Touch
- 10.3.1.12. MiniOpticon
- 10.3.1.13. Others
- 10.3.2. Liquid Handling Systems
- 10.3.2.1. epMotion
- 10.3.2.2. Biomek
- 10.3.2.3. Freedom EVO
- 10.3.2.4. Tecan D300e Digital Dispenser
- 10.3.2.5. Precision
- 10.3.2.6. JANUS
- 10.3.2.7. Others
- 10.3.3. DNA Extraction Systems
- 10.3.3.1. AutoMate Express
- 10.3.3.2. QIAcube
- 10.3.3.3. InnuPure
- 10.3.3.4. VERSA
- 10.3.3.5. Chemagic
- 10.3.3.6. Others
- 10.3.1. Real-time PCR Systems
- 10.4. Market Value Forecast, by End-user, 2020-2034
- 10.4.1. Hospitals
- 10.4.2. Diagnostics Laboratories
- 10.4.3. Academic & Research Institutes
- 10.4.4. Pharmaceutical & Biotechnology Companies
- 10.5. Market Attractiveness Analysis
- 10.5.1. By Product
- 10.5.2. By End-user
11. U.K. Molecular Diagnostics Market Analysis and Forecast
- 11.1. Introduction
- 11.2. Key Findings
- 11.3. Market Value Forecast, by Product, 2020-2034
- 11.3.1. Real-time PCR Systems
- 11.3.1.1. LightCycler 480
- 11.3.1.2. PCRmax Eco 48
- 11.3.1.3. Applied Biosystems 7900HT
- 11.3.1.4. QuantStudio Real-Time PCR
- 11.3.1.5. ViiA 7 Real-Time PCR
- 11.3.1.6. C1000 Touch
- 11.3.1.7. ABI StepOnePlus Real-Time PCR
- 11.3.1.8. 5ABI 7500
- 11.3.1.9. AriaMx Real-time PCR System
- 11.3.1.10. CFX Connect
- 11.3.1.11. CFX384 Touch
- 11.3.1.12. MiniOpticon
- 11.3.1.13. Others
- 11.3.2. Liquid Handling Systems
- 11.3.2.1. epMotion
- 11.3.2.2. Biomek
- 11.3.2.3. Freedom EVO
- 11.3.2.4. Tecan D300e Digital Dispenser
- 11.3.2.5. Precision
- 11.3.2.6. JANUS
- 11.3.2.7. Others
- 11.3.3. DNA Extraction Systems
- 11.3.3.1. AutoMate Express
- 11.3.3.2. QIAcube
- 11.3.3.3. InnuPure
- 11.3.3.4. VERSA
- 11.3.3.5. Chemagic
- 11.3.3.6. Others
- 11.3.1. Real-time PCR Systems
- 11.4. Market Value Forecast, by End-user, 2020-2034
- 11.4.1. Hospitals
- 11.4.2. Diagnostics Laboratories
- 11.4.3. Academic & Research Institutes
- 11.4.4. Pharmaceutical & Biotechnology Companies
- 11.5. Market Attractiveness Analysis
- 11.5.1. By Product
- 11.5.2. By End-user
12. France Molecular Diagnostics Market Analysis and Forecast
- 12.1. Introduction
- 12.2. Key Findings
- 12.3. Market Value Forecast, by Product, 2020-2034
- 12.3.1. Real-time PCR Systems
- 12.3.1.1. LightCycler 480
- 12.3.1.2. PCRmax Eco 48
- 12.3.1.3. Applied Biosystems 7900HT
- 12.3.1.4. QuantStudio Real-Time PCR
- 12.3.1.5. ViiA 7 Real-Time PCR
- 12.3.1.6. C1000 Touch
- 12.3.1.7. ABI StepOnePlus Real-Time PCR
- 12.3.1.8. 5ABI 7500
- 12.3.1.9. AriaMx Real-time PCR System
- 12.3.1.10. CFX Connect
- 12.3.1.11. CFX384 Touch
- 12.3.1.12. MiniOpticon
- 12.3.1.13. Others
- 12.3.2. Liquid Handling Systems
- 12.3.2.1. epMotion
- 12.3.2.2. Biomek
- 12.3.2.3. Freedom EVO
- 12.3.2.4. Tecan D300e Digital Dispenser
- 12.3.2.5. Precision
- 12.3.2.6. JANUS
- 12.3.2.7. Others
- 12.3.3. DNA Extraction Systems
- 12.3.3.1. AutoMate Express
- 12.3.3.2. QIAcube
- 12.3.3.3. InnuPure
- 12.3.3.4. VERSA
- 12.3.3.5. Chemagic
- 12.3.3.6. Others
- 12.3.1. Real-time PCR Systems
- 12.4. Market Value Forecast, by End-user, 2020-2034
- 12.4.1. Hospitals
- 12.4.2. Diagnostics Laboratories
- 12.4.3. Academic & Research Institutes
- 12.4.4. Pharmaceutical & Biotechnology Companies
- 12.5. Market Attractiveness Analysis
- 12.5.1. By Product
- 12.5.2. By End-user
13. Germany Molecular Diagnostics Market Analysis and Forecast
- 13.1. Introduction
- 13.2. Key Findings
- 13.3. Market Value Forecast, by Product, 2020-2034
- 13.3.1. Real-time PCR Systems
- 13.3.1.1. LightCycler 480
- 13.3.1.2. PCRmax Eco 48
- 13.3.1.3. Applied Biosystems 7900HT
- 13.3.1.4. QuantStudio Real-Time PCR
- 13.3.1.5. ViiA 7 Real-Time PCR
- 13.3.1.6. C1000 Touch
- 13.3.1.7. ABI StepOnePlus Real-Time PCR
- 13.3.1.8. 5ABI 7500
- 13.3.1.9. AriaMx Real-time PCR System
- 13.3.1.10. CFX Connect
- 13.3.1.11. CFX384 Touch
- 13.3.1.12. MiniOpticon
- 13.3.1.13. Others
- 13.3.2. Liquid Handling Systems
- 13.3.2.1. epMotion
- 13.3.2.2. Biomek
- 13.3.2.3. Freedom EVO
- 13.3.2.4. Tecan D300e Digital Dispenser
- 13.3.2.5. Precision
- 13.3.2.6. JANUS
- 13.3.2.7. Others
- 13.3.3. DNA Extraction Systems
- 13.3.3.1. AutoMate Express
- 13.3.3.2. QIAcube
- 13.3.3.3. InnuPure
- 13.3.3.4. VERSA
- 13.3.3.5. Chemagic
- 13.3.3.6. Others
- 13.3.1. Real-time PCR Systems
- 13.4. Market Value Forecast, by End-user, 2020-2034
- 13.4.1. Hospitals
- 13.4.2. Diagnostics Laboratories
- 13.4.3. Academic & Research Institutes
- 13.4.4. Pharmaceutical & Biotechnology Companies
- 13.5. Market Attractiveness Analysis
- 13.5.1. By Product
- 13.5.2. By End-user
14. Competition Landscape
- 14.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
- 14.2. Market Share Analysis, by Company (2023)
- 14.3. Company Profiles
- 14.3.1. Agilent Technologies, Inc.
- 14.3.1.1. Company Overview
- 14.3.1.2. Product Portfolio
- 14.3.1.3. SWOT Analysis
- 14.3.1.4. Financial Overview
- 14.3.1.5. Strategic Overview
- 14.3.2. BD
- 14.3.2.1. Company Overview
- 14.3.2.2. Product Portfolio
- 14.3.2.3. SWOT Analysis
- 14.3.2.4. Financial Overview
- 14.3.2.5. Strategic Overview
- 14.3.3. Bio-Rad Laboratories, Inc.
- 14.3.3.1. Company Overview
- 14.3.3.2. Product Portfolio
- 14.3.3.3. SWOT Analysis
- 14.3.3.4. Financial Overview
- 14.3.3.5. Strategic Overview
- 14.3.4. Danaher
- 14.3.4.1. Company Overview
- 14.3.4.2. Product Portfolio
- 14.3.4.3. SWOT Analysis
- 14.3.4.4. Financial Overview
- 14.3.4.5. Strategic Overview
- 14.3.5. Eppendorf SE
- 14.3.5.1. Company Overview
- 14.3.5.2. Product Portfolio
- 14.3.5.3. SWOT Analysis
- 14.3.5.4. Financial Overview
- 14.3.5.5. Strategic Overview
- 14.3.6. F. Hoffmann-La Roche Ltd.
- 14.3.6.1. Company Overview
- 14.3.6.2. Product Portfolio
- 14.3.6.3. SWOT Analysis
- 14.3.6.4. Financial Overview
- 14.3.6.5. Strategic Overview
- 14.3.7. PerkinElmer, Inc.
- 14.3.7.1. Company Overview
- 14.3.7.2. Product Portfolio
- 14.3.7.3. SWOT Analysis
- 14.3.7.4. Financial Overview
- 14.3.7.5. Strategic Overview
- 14.3.8. Tecan Trading AG
- 14.3.8.1. Company Overview
- 14.3.8.2. Product Portfolio
- 14.3.8.3. SWOT Analysis
- 14.3.8.4. Financial Overview
- 14.3.8.5. Strategic Overview
- 14.3.9. Thermo Fisher Scientific, Inc.
- 14.3.9.1. Company Overview
- 14.3.9.2. Product Portfolio
- 14.3.9.3. SWOT Analysis
- 14.3.9.4. Financial Overview
- 14.3.9.5. Strategic Overview
- 14.3.10. QIAGEN
- 14.3.10.1. Company Overview
- 14.3.10.2. Product Portfolio
- 14.3.10.3. SWOT Analysis
- 14.3.10.4. Financial Overview
- 14.3.10.5. Strategic Overview
- 14.3.1. Agilent Technologies, Inc.
Product Code: TMRGL9434
List of Tables
- Table 01: Europe Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product, 2020-2034
- Table 02: Europe Molecular Diagnostics Market Volume (Units) Forecast, by Product, 2020-2034
- Table 03: Europe Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
- Table 04: Europe Molecular Diagnostics Market Value (US$ Mn) Forecast, by Country, 2020-2034
- Table 05: Italy Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product, 2020-2034
- Table 06: Italy Molecular Diagnostics Market Volume (Units) Forecast, by Product, 2020-2034
- Table 07: Italy Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
- Table 08: Italy Molecular Diagnostics Market Value (US$ Mn) Forecast, by Country, 2020-2034
- Table 09: Spain Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product, 2020-2034
- Table 10: Spain Molecular Diagnostics Market Volume (Units) Forecast, by Product, 2020-2034
- Table 11: Spain Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
- Table 12: Spain Molecular Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
- Table 13: U.K. Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product, 2020-2034
- Table 14: U.K. Molecular Diagnostics Market Volume (Units) Forecast, by Product, 2020-2034
- Table 15: U.K. Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
- Table 16: U.K. Molecular Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
- Table 17: France Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product, 2020-2034
- Table 18: France Molecular Diagnostics Market Volume (Units) Forecast, by Product, 2020-2034
- Table 19: France Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
- Table 20: France Molecular Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
- Table 21: Germany Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product, 2020-2034
- Table 22: Germany Molecular Diagnostics Market Volume (Units) Forecast, by Product, 2020-2034
- Table 23: Germany Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
- Table 24: Germany Molecular Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
List of Figures
- Figure 01: Europe Molecular Diagnostics Market Size (US$ Mn) and Distribution (%), by Country, 2023 and 2034
- Figure 02: Europe Molecular Diagnostics Market Revenue (US$ Mn), by Product, 2023
- Figure 03: Europe Molecular Diagnostics Market Value Share, by Product, 2023
- Figure 04: Europe Molecular Diagnostics Market Revenue (US$ Mn), by End-user, 2023
- Figure 05: Europe Molecular Diagnostics Market Value Share, by End-user, 2023
- Figure 06: Europe Molecular Diagnostics Market Value Share, by Country, 2023
- Figure 07: Europe Molecular Diagnostics Market Value (US$ Mn) Forecast, 2023-2034
- Figure 08: Europe Molecular Diagnostics Market Value Share Analysis, by Product, 2023 and 2034
- Figure 09: Europe Molecular Diagnostics Market Attractiveness Analysis, by Product, 2023-2034
- Figure 10: Europe Molecular Diagnostics Market Value Share Analysis, by End-user, 2023 and 2034
- Figure 11: Europe Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2023-2034
- Figure 12: Europe Molecular Diagnostics Market Value Share Analysis, by Country, 2023 and 2034
- Figure 13: Europe Molecular Diagnostics Market Attractiveness Analysis, by Country, 2023-2034
- Figure 14: Italy Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
- Figure 15: Italy Molecular Diagnostics Market Value Share Analysis, by Product, 2023 and 2034
- Figure 16: Italy Molecular Diagnostics Market Value Share Analysis, by End-user, 2023 and 2034
- Figure 17: Italy Molecular Diagnostics Market Attractiveness Analysis, by Product, 2023-2034
- Figure 18: Italy Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2023-2034
- Figure 19: Spain Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
- Figure 20: Spain Molecular Diagnostics Market Value Share Analysis, by Product, 2023 and 2034
- Figure 21: Spain Molecular Diagnostics Market Value Share Analysis, by End-user, 2023 and 2034
- Figure 22: Spain Molecular Diagnostics Market Attractiveness Analysis, by Product, 2023-2034
- Figure 23: Spain Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2023-2034
- Figure 24: U.K. Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
- Figure 25: U.K. Molecular Diagnostics Market Value Share Analysis, by Product, 2023 and 2034
- Figure 26: U.K. Molecular Diagnostics Market Value Share Analysis, by End-user, 2023 and 2034
- Figure 27: U.K. Molecular Diagnostics Market Attractiveness Analysis, by Product, 2023-2034
- Figure 28: U.K. Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2023-2034
- Figure 29: France Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
- Figure 30: France Molecular Diagnostics Market Value Share Analysis, by Product, 2023 and 2034
- Figure 31: France Molecular Diagnostics Market Value Share Analysis, by End-user, 2023 and 2034
- Figure 32: France Molecular Diagnostics Market Attractiveness Analysis, by Product, 2023-2034
- Figure 33: France Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2023-2034
- Figure 34: Germany Molecular Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
- Figure 35: Germany Molecular Diagnostics Market Value Share Analysis, by Product, 2023 and 2034
- Figure 36: Germany Molecular Diagnostics Market Value Share Analysis, by End-user, 2023 and 2034
- Figure 37: Germany Molecular Diagnostics Market Attractiveness Analysis, by Product, 2023-2034
- Figure 38: Germany Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2023-2034
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.